FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, IS ACTIVE IN THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kuter, David J
  • Arnold, Donald
  • Agajanian, Richy
  • Choi, Michael
  • Lichtin, Alan
  • Rogers, Kerry A
  • Boxer, Michael A
  • Broome, Catherine
  • Field, Joshua J
  • Murakhovskaya, Irina
  • Lowe, Ann M
  • Zayed, Hany
  • Tong, Sandra
  • Duliege, Anne-Marie

publication date

  • September 1, 2018